Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

83 days since the 12/21/17 pr stating final patient inp2b trial.

58 days(eight weeks and two days) since the 1/16/18 pr which included the following LE quote:

“Datasets now in hand, reflecting three successfully completed Phase 2 studies across which multiple endpoints were met, have brought the Company to an important inflection point regarding Brilacidin. In coming weeks, we look forward to advancing these discussions with attractive partnership / licensing scenarios, towards determining the best path forward for the Company and its loyal shareholders.”

News has to close. If not LE should clarify coming ¨weeks¨.